These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 777003)

  • 21. [Evaluation of the postvaccination level of influenza antibodies by means of the radial immunodiffusion and hemagglutination inhibition reactions].
    Vavilova IuG; Gorev NE; Zykov MP
    Vopr Virusol; 1976; (2):158-61. PubMed ID: 820079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WRL 105 strain (H3N2) live attenuated influenza vaccine: acceptability, reactivity, and antibody response in normal, bronchitic, and geriatric volunteers.
    Nicholson KG; Tyrrell DA; Freestone DS
    Lancet; 1976 Jun; 1(7973):1309-11. PubMed ID: 58306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further trials of live influenza vaccine.
    Andrews BE; Beare AS; McDonald JC; Zuckerman AJ; Tyrrell DA
    Br Med J; 1966 Mar; 1(5488):637-40. PubMed ID: 5908709
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies with a live influenza A vaccine in army personnel.
    Donaldson A; Winsor HJ; Bennett NM; Gust ID
    Pathology; 1977 Jan; 9(1):49-56. PubMed ID: 323793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses to vaccination with WRL 105 strain live influenza vaccine in previously vaccinated and unvaccinated volunteers.
    Evans AE; Simmons RL; Ferris RD; Hasell SK; Letley E; Freestone DS
    J Hyg (Lond); 1979 Jun; 82(3):489-95. PubMed ID: 448065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of influenza by vaccines administered intramuscularly and intradermally].
    Trivello R; Gasparini V; Moschen ME; Romano M; Farisano G; Manicardi GC
    Ann Sclavo; 1972; 14(6):705-15. PubMed ID: 4130435
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
    Petrie JG; Ohmit SE; Truscon R; Johnson E; Braun TM; Levine MZ; Eichelberger MC; Monto AS
    J Infect Dis; 2016 Oct; 214(8):1142-9. PubMed ID: 27095420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research on influenza vaccination with A2 + B vaccine].
    Bellelli E; Nardi G; Bracchi U; Tanzi ML; Monaci V; Sansebastiano G
    Ann Sclavo; 1971; 13(5):584-96. PubMed ID: 5153401
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 31. Small-scale trial of live-attenuated influenza vaccine (A/Hong Kong/68).
    West R; Stewart JA; White FM; McDonald JC; Boudreault A; Pavilanis V
    Can J Microbiol; 1977 Mar; 23(3):253-7. PubMed ID: 322827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16.
    Spencer MJ; Cherry JD; Terasaki PI
    N Engl J Med; 1976 Jan; 294(1):13-6. PubMed ID: 1105178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy.
    Rytel MW; Jackson LJ; Ferstenfeld JE; Rosenkranz MA
    J Infect Dis; 1975 Dec; 132(6):652-9. PubMed ID: 1202110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical and serologic comparison of standard and purified bivalent inactivated influenza vaccines.
    Finklea JF; Sandifer SH; Peck FB; Manos JP
    J Infect Dis; 1969 Dec; 120(6):708-12. PubMed ID: 4911903
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine.
    Spencer MJ; Cherry JD; Powell KR; Sumaya CV; Garakian AJ
    J Infect Dis; 1975 Oct; 132(4):415-20. PubMed ID: 1102614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.
    Curtis D; Ning MF; Armon C; Li S; Weinberg A
    Vaccine; 2015 Sep; 33(38):4790-7. PubMed ID: 26241950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.
    Ohmit SE; Petrie JG; Cross RT; Johnson E; Monto AS
    J Infect Dis; 2011 Dec; 204(12):1879-85. PubMed ID: 21998477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 40. Alice strain live attenuated influenza (H3N2) vaccin in an elderly population.
    Miller LW; Hume EB; O'Brien FR; Togo Y; Hornick RB
    Am J Epidemiol; 1975 Apr; 101(4):340-6. PubMed ID: 1168413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.